Rob Wallis

2020-06-17T09:43:28+01:00

Meet The Team

Robert Wallis Low Res crop

Dr Rob Wallis

PhD

Rob is a pharmacologist by training with expertise in drug discovery and development.  He has more than 30 years industry experience as head of Safety pharmacology at Pfizer with a world-wide reputation in the area of drug-induced QT prolongation/non-clinical cardiovascular safety.  He has presented at many scientific conferences and at the FDA and is a member of the ICH E14 Q&A Technical Group.  He is a former member of the Board of Directors of the Safety Pharmacology Society.

Mike
Mike ODonovan
Annette 1 800
Annette Zaar
Drug safety
Drug Project Toxicology

Marie Cumberbatch

2020-01-22T11:25:17+00:00

Meet The Team

Marie 800

Marie Cumberbatch

MSc

Marie is an established immunologist with over 30 years of experience gained in industry and academia. She has specific immune expertise in oncology and toxicology, most recently in the field of immuno-oncology biomarkers for efficacy, mode of action, patient selection and safety across all phases of the drug discovery process from early target identification through to clinical trials. Marie has many peer reviewed publications in her specialist area of immunology and is a former team leader the AstraZeneca Oncology Translation Sciences.

Jane Stewart | Toxicologist | ApconiX
Jane Stewart
Peter Ballard | Toxicologist | ApconiX
Peter Ballard
Drug safety
Drug Project Toxicology

Damian Deavall

2020-01-22T11:24:48+00:00

Meet The Team

Damian

Dr Damian Deavall

PhD

Damian is a project leader with broad expertise in global drug development across multiple modalities, including small molecules, antibodies, peptides, oligonucleotides, therapeutic viruses and vaccines. He has 20 years of experience in the pharmaceutical industry from early phase discovery, through development to registration across multiple therapy areas including oncology, infectious disease and metabolic disorders. He has led the safety assessment of more than 30 candidate drug programmes, bringing new therapies to clinical trials at all phases and completing marketing approval applications in the EU and US. He specializes in leading and managing drug safety programmes within complex alliances and partnerships.  Damian brings wit and wisdom to projects to drive a cross-discipline collaboration.

Dr Paul Duffy
Paul Duffy
Robert Wallis | Toxicologist | ApconiX
Rob Wallis
Drug safety
Drug Project Toxicology

Peter Ballard

2020-01-22T11:24:13+00:00

Meet The Team

Peter Ballard | Toxicologist | ApconiX

Dr Peter Ballard

PhD

Peter is a senior drug metabolism and pharmacokinetic (DMPK) expert with extensive experience in global discovery and development projects. He has a proven track record of international project delivery from early drug discovery through to development and compound registration from over 30 years in the pharmaceutical industry and has maintained a high academic profile with more than 30 publications in peer reviewed journals and presentations at international conference.

Jane Stewart | Toxicologist | ApconiX
Jane Stewart
Damian
Damian Deavall
Drug safety
Drug Project Toxicology

Mike O’Donovan

2019-12-06T14:00:06+00:00

Meet The Team

Mike

Dr Mike O’Donovan

DPhil, FRCPath

Mike is a senior toxicologist with an international reputation in the field of genetic toxicology. He has over 35 years’ experience in the pharmaceutical industry and has over 65 peer-reviewed publications. As a former Director of Genetic Toxicology at AstraZeneca, he has worked as an independent consultant supporting several companies in the UK and Europe. Mike is currently a member of the Department of Health Committee on Mutagenicity and is a Fellow of the UK Environmental Mutagen Society.

Peter Ballard | Toxicologist | ApconiX
Peter Ballard
Dr Paul Duffy
Paul Duffy
Drug safety
Drug Project Toxicology

Jane Stewart

2020-01-22T11:17:28+00:00

Meet The Team

Jane Stewart | Toxicologist | ApconiX

Dr Jane Stewart

PhD, ERT, BVM&S, MRCVS

Jane is a senior toxicologist with world leading expertise in reproductive toxicology and the safety assessment of pharmaceuticals. Jane is renowned for her expertise in problem solving for general and reproductive toxicology as well as in the investigation of endocrine effects and carcinogenesis. Jane has authored numerous pregnancy labels and has helped draft international testing guidelines for pharmaceuticals. Jane is a PhD qualified veterinarian with a degree in pathological sciences.  Jane is known for her analytical mindset and ability to identify and resolve key issues.

Mike
Mike O’Donovan
Peter Ballard | Toxicologist | ApconiX
Peter Ballard
Drug safety
Drug Project Toxicology

William O’Brien

2020-01-22T11:32:11+00:00

Meet The Team

William obrien

William O’Brien

MA, MBA

William is a specialist R&D tax and finance advisor.  A seasoned leader, he has worked across a wide range of industries including Biotech, Medical Devices, Formula One, Defence and Finance. William has a degree in Neurophysiology from the University of Cambridge and an MBA from Manchester Business School.  William is a natural fit for ApconiX as he began his career working as a scientist at the Babraham Institute near Cambridge, using patch clamp and fluorescence imaging to study the role of GTP binding proteins in exocytosis.

Julie Knight e1575639750292
Julie Knight
Olivia Turner | ApconiX
Olivia Turner
Ion Channel Screening e1575562532574
Home

Kimberley Rockley

2020-01-22T11:32:55+00:00

Meet The Team

Kim

Dr Kimberly Rockley

PhD

Kim holds a PhD in Pharmacy from Durham University where she studied anthracycline-induced cardiotoxicity and its mitigation by in vitro.  Before this, Kim gained with a BSc in Biomedical Science and a Master’s degree in Cancer Pharmacology from the University of Bradford, graduating with distinction. She also has experience as a Clinical Trial Coordinator at the Haematology and Oncology Centre, University Hospitals Bristol NHS foundation Trust.   Kim is a creative research scientist who enjoys the busy and dynamic environment of ApconiX.

Dr Michael Morton
Michael Morton
Karen Jones e1575639519826
Karen Jones
Ion Channel Screening e1575562532574
Ion Channel Screening

Russell Huby

2020-01-22T11:23:39+00:00

Meet The Team

Russell Huby

Dr Russell Huby

PhD

Russell is an experienced toxicologist with expertise in oncology, discovery project toxicology and investigative mechanistic toxicology.  He has extensive experience in early stage projects gained from over 20 years in the pharmaceutical industry and has conducted numerous target safety reviews across multiple therapy areas.  Russell is a pragmatic problem-solver with an eye for the possible and the practicable.

01 Ruth Roberts2 300x300 e1575561666261
Ruth Roberts
Claire 1 e1575564629770
Claire Sadler
Acuity Image
Target Safety Assessments

Ian Slater

2020-01-22T11:23:14+00:00

Meet The Team

Ian Slater

Ian Slater

MSc

Ian is an experienced toxicology Study Director and Study Monitor with expertise in GLP and non-GLP toxicology studies across diverse therapy areas.  He has extensive experience in working with CROs gained during his more than 20 years at AstraZeneca.  Ian was Chair of the Study Director Workshop of the British Toxicology Society from 2011-2015, providing a forum for the sharing of good practice and supporting the development of junior toxicologists.  Ian is a practical and pragmatic toxicologist who brings his wealth of experience to the design, conduct, delivery and reporting of toxicology studies.

Rich21 e1575560748215
Richard Knight
Guy Healing 682 e1575630362171
Guy Healing
iStock 840610244 e1575563457203
Nonclinical Study Monitoring